India's Glenmark Life Sciences rises after qtrly profit jump

Alivus Life Sciences

11/11/2021 04:15

** Shares of active pharma ingredients maker  GLEM.NS  rise
5.1% to 664.90 rupees, highest level in over 3 weeks
    ** Glenmark Life Sciences after market hours on Wednesday
posted 59% jump in Sept-qtr profit to 1.15 bln rupees ($15.47
mln), fuelled by increased demand in key regulated markets
 urn:newsml:reuters.com:*:nFWN2S131I
    ** "Despite multiple headwinds coming from spike in input
prices, logistics costs and energy prices, we have sustained
healthy EBITDA margin of 30.2% for the quarter" - Bhavesh
Pujara, CFO
    ** Co also declared an interim dividend of 10.50
rupees/share for financial year ending March 31, 2022
    ** Despite session's gains, GLEM shares down over 11% since
Aug market debut


($1 = 74.3325 Indian rupees)

 (Reporting by Shivani Singh in Bengaluru)
 ((ShivaniSingh1@thomsonreuters.com; +91 89 6969 2349))